Episoder

  • In this episode, Martin Witzenrath, MD, FERS, and Michele Bartoletti, MD, PhD, discuss the management of mild to moderate COVID-19 in patients who are immunocompromised, including:

    Initial workup, which may include laboratory tests and/or imagingLatest data on the use of remdesivir or nirmatrelvir plus ritonavir for mild to moderate COVID-19, including considerations for drug–drug interactions

    Presenters:

    Martin Witzenrath, MD, FERS
    Medical Director
    Charite Centrum 12
    Internal Medicine & Dermatology
    Professor and Chair for Respiratory Medicine and Critical Care
    Department of Infectious Disease, Respiratory Medicine and Critical Care
    Charite Campus Mitte/Campus Virchow Klinikum/Campus Benjamin Franklin
    Charite – University of Berlin
    Berlin, Germany

    Michele Bartoletti, MD, PhD
    Associate Professor of Infectious Diseases
    Department of Biomedical Sciences
    Humanitas University
    Pieve Emanuele (MI), Italy
    Head of Infectious Diseases Unit
    IRCCS Humanitas Research Hospital
    Rozzano (MI), Italy

    Link to full program:
    https://bit.ly/4gu2gcU

    Downloadable slides:
    https://bit.ly/3CGlDBS

    Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

  • In this episode, Patricia D. Jones, MD, MSCR; Mindie H. Nguyen, MD, MAS, AGAF, FAASLD; and patient advocate, Jennifer Wild, MS, RN, OCN, discuss best practices in hepatitis B virus (HBV) care, including:

    2023 CDC HBV screening recommendationsSummary of guideline recommendations for hepatitis delta virus (HDV) screening Use of HDV reflex testing to avoid loss to follow-up2024 WHO HBV treatment recommendations, including recommendations for pregnant persons

    Presenters:

    Patricia D. Jones, MD, MSCR
    Associate Professor of Clinical Medicine
    Director of Clinical Operations-Hepatology
    Division of Digestive Health and Liver Diseases
    Department of Medicine
    University of Miami Miller School of Medicine
    Sylvester Comprehensive Cancer Center
    Miami, Florida

    Mindie H. Nguyen, MD, MAS, AGAF, FAASLD
    Professor of Medicine (GI & Hepatology,
    Liver Transplant)
    Professor of Epidemiology & Population Health
    (by Courtesy)
    Director of Hepatology Clerkship
    Faculty Search LENS Advocates,
    Stanford Department of Medicine
    Faculty Fellow, Stanford Center for Innovation
    in Global Health
    Member, Stanford Cancer Institute, Maternal &
    Child Health Research Institute, & Stanford Bio-C
    Stanford, California

    Past Chair: HBV SIG, The American Association for the Study of Liver Diseases (AASLD)

    28th President: The International Association for the Study of the Liver (IASL)

    Jennifer Wild, MS, RN, OCN
    Clinical Nurse – GI Medical Oncology
    UCSF Cancer Center
    San Francsico, California

    Link to full program:
    https://bit.ly/4j973TN

    Downloadable slides:
    https://bit.ly/3WQkIWl

    Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

  • Manglende episoder?

    Klik her for at forny feed.

  • In this episode, Cristina Mussini, MD, Martin Witzenrath, MD, FERS, and Michele Bartoletti, MD, PhD, discuss:

    Current SARS-CoV-2 trends in the EURisk factors for severe COVID-19 outcomes, including the spectrum of risk based on immune system statusFactors that may affect vaccine efficacy in chronic lymphocytic leukemia and other lymphoid malignanciesConsiderations for determining people at high risk for COVID-19 progression

    Presenters:

    Cristina Mussini, MD
    Full Professor of Infectious Diseases
    Division of Infectious Diseases
    University of Modena and Reggio Emilia
    Modena, Italy

    Martin Witzenrath, MD, FERS
    Medical Director
    Charite Centrum 12
    Internal Medicine & Dermatology
    Professor and Chair for Respiratory Medicine and Critical Care
    Department of Infectious Disease, Respiratory Medicine and Critical Care
    Charite Campus Mitte/Campus Virchow Klinikum/Campus Benjamin Franklin
    Charite – University of Berlin
    Berlin, Germany

    Michele Bartoletti, MD, PhD
    Associate Professor of Infectious Diseases
    Department of Biomedical Sciences
    Humanitas University
    Pieve Emanuele (MI), Italy
    Head of Infectious Diseases Unit
    IRCCS Humanitas Research Hospital
    Rozzano (MI), Italy

    Link to full program:
    https://bit.ly/4gu2gcU

    Downloadable slides:
    https://bit.ly/42IlpEL

    Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

  • In this episode, Tzu-Hao (Howard) Lee, MD; Tatyana Kushner, MD, MSCE; and patient advocate Andrew Reynolds discuss hepatitis C virus (HCV) care in men who have sex with men and pregnant people, including:

    HCV disease burden in the United StatesScreening recommendations Strategies to overcome barriers to HCV screeningTreatment recommendations, including simplified treatment guidance and considerations for pregnant peopleStrategies to improve treatment uptake


    Presenters:

    Tzu-Hao (Howard) Lee, MD
    Assistant Professor
    Section of Gastroenterology and Hepatology, Department of Medicine
    Division of Abdominal Transplant, Department of Surgery
    Baylor College of Medicine
    Houston, Texas

    Tatyana Kushner, MD, MSCE
    Associate Professor
    Division of Gastroenterology/Hepatology
    Department of Obstetrics & Gynecology
    Weill Cornell Medicine
    New York, New York

    Andrew Reynolds
    Director, Health of People Who Use Drugs
    San Francisco AIDS Foundation
    San Francisco, California

    To access all of our new podcast episodes, subscribe to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. 

    Link to full program:
    https://bit.ly/4j973TN

    Downloadable slides:
    https://bit.ly/4gXuBcu

  • In this episode, Sonal Kumar, MD, MPH, discusses key findings from primary biliary cholangitis (PBC) studies presented at AASLD 2024, including:

    ELATIVE, a phase III trial of elafibranor for PBCRESPONSE, a phase III trial of seladelpar for PBCASSURE, another phase III trial of seladelpar for PBC

    Presenter:
    Sonal Kumar, MD, MPH
    Director, Clinical Gastroenterology and Hepatology
    Assistant Professor of Medicine
    Weill Cornell Medical College
    New York, New York

    Link to full program:
    https://bit.ly/41tvSDu

    Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

  • Listen in as Stephen Cantrill, MD, FACEP; Rajesh T. Gandhi, MD; and Payal K. Patel, MD, MPH, FIDSA, discuss current trends in and risk factors for progression to severe COVID-19, including for those for whom COVID-19 is not their primary concern when presenting to the emergency department (ED). Key topics of discussion include:

    How to complete a comprehensive patient workup in the EDConsiderations regarding pulse oximetryRisk stratification—what places patients at higher risk of severe disease?A detailed patient case to illustrate key takeaways

    Presenters:

    Stephen Cantrill, MD, FACEP​
    Associate Director and Medical Director (Retired) ​
    Department of Emergency Medicine​
    Denver Health Medical Center​
    Associate Professor ​
    Department of Emergency Medicine​
    University of Colorado Health Sciences Center​
    Denver, Colorado

    Rajesh T. Gandhi, MD​
    Massachusetts General Hospital​
    Professor of Medicine​
    Harvard Medical School​
    Boston, Massachusetts

    Payal K. Patel, MD, MPH, FIDSA​
    Systemwide Director of Antimicrobial Stewardship​
    Associate Professor, Division of Infectious Diseases​
    Intermountain Health​
    Salt Lake City, Utah

    Link to full program:
    https://bit.ly/4fs7Hcb

    Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

  • In this episode, Stacey B. Trooskin, MD, PhD, MPH, Mark S. Sulkowski, MD, FIDSA, FAASLD, and Ronni Marks discuss hepatitis C virus (HCV) screening and treatment, focusing on people who use drugs, and highlight the following topics:

    Screening recommendationsStrategies to improve HCV screeningHCV testingTreatment goalsStrategies to improve HCV treatment uptake

    Presenters:

    Stacey B. Trooskin, MD, PhD, MPH
    Executive Medical Officer
    Mazzoni Center
    Faculty, University of Pennsylvania
    Perelman School of Medicine
    Philadelphia, Pennsylvania

    Mark S. Sulkowski, MD, FIDSA, FAASLD
    Professor of Medicine
    Director, Division of Infectious Diseases Johns Hopkins Bayview Medical Center
    Johns Hopkins University School of Medicine
    Baltimore, Maryland

    Ronni Marks
    Founder/Director, The Hepatitis C Mentor and Support Group (HCMSG)
    Patient Advocate
    New York, New York

    Link to full program:
    https://bit.ly/4grbwPT

  • Listen in as Stephen Cantrill, MD, FACEP; Rajesh T. Gandhi, MD; and Payal K. Patel, MD, MPH, FIDSA, discuss best practices in treating patients hospitalized with mild to moderate COVID-19, including:

    Current guidelines from the Infectious Diseases Society of America and National Institutes of Health How to optimize therapy selection based on patient risk factors, including key data supporting best practicesA detailed patient case to illustrate key takeaways

    Presenters:

    Stephen Cantrill, MD, FACEP​
    Associate Director and Medical Director (Retired) ​
    Department of Emergency Medicine​
    Denver Health Medical Center​
    Associate Professor ​
    Department of Emergency Medicine​
    University of Colorado Health Sciences Center​
    Denver, Colorado

    Rajesh T. Gandhi, MD​
    Massachusetts General Hospital​
    Professor of Medicine​
    Harvard Medical School​
    Boston, Massachusetts

    Payal K. Patel, MD, MPH, FIDSA​
    Systemwide Director of Antimicrobial Stewardship​
    Associate Professor, Division of Infectious Diseases​
    Intermountain Health​
    Salt Lake City, Utah

    Link to full program:
    https://bit.ly/4fs7Hcb

    Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

  • Clinical gaps in the treatment of pruritus in primary biliary cholangitis (PBC) remain. In this episode, taken from a recent symposium, Marlyn J. Mayo, MD; Stuart C. Gordon, MD; and Pam Rivard, RN, a person living with PBC, discuss emerging therapies currently in clinical trials for the management of this disease that can dramatically affect patients’ quality of life.

    Listen as they discuss:

    Gaps in current managementPatient perspectives: why we should not dismiss itching as an underlying psychologic problemPPAR agonists and how they affect pruritusBEZURSO and FITCH ELATIVEENHANCE and RESPONSEIBATs (inhibitors of bile acid transport)GLIMMERCommon questions

    Presenters:

    Marlyn J. Mayo, MD
    Professor of Internal Medicine
    Division of Digestive & Liver Diseases
    UT Southwestern Medical Center
    Dallas, Texas

    Stuart C. Gordon, MD
    Professor of Medicine
    Wayne State University School of Medicine
    Director, Division of Hepatology
    Henry Ford Health
    Detroit, Michigan

    Pam Rivard, RN
    Person living with PBC

    Link to full program:
    https://bit.ly/3Dnfb2E

  • Although there is currently no FDA-approved treatment for pruritus in primary biliary cholangitis (PBC), symptoms can be mitigated with nonpharmacologic or pharmacologic agents. In this episode, Marlyn J. Mayo, MD; Stuart C. Gordon, MD; and Pam Rivard, RN, a person living with PBC, discuss the clinical management of pruritus in PBC, including:

    Pruritus assessment toolsOptimal use of tools, including frequency of assessmentCurrent management of pruritusNonpharmacologic interventionsPharmacologic agentsStrategies to optimize assessment and management of pruritusCollaborative careDevelopment of a treatment planOngoing assessment and adjustment of therapyResources and support for patients

    Presenters:

    Marlyn J. Mayo, MD
    Professor of Internal Medicine
    Division of Digestive & Liver Diseases
    UT Southwestern Medical Center
    Dallas, Texas

    Stuart C. Gordon, MD
    Professor of Medicine
    Wayne State University School of Medicine
    Director, Division of Hepatology
    Henry Ford Health
    Detroit, Michigan

    Pam Rivard, RN
    Person living with PBC

    Link to full program:
    https://bit.ly/3Dnfb2E

  • In this episode, Marlyn J. Mayo, MD; Stuart C. Gordon, MD; and Pam Rivard, RN, a person living with primary biliary cholangitis (PBC), discuss the burden of pruritus in PBC and the impact it has on quality of life, including both physical and mental health, from a patient’s perspective.

    Presenters:

    Marlyn J. Mayo, MD
    Professor of Internal Medicine
    Division of Digestive & Liver Diseases
    UT Southwestern Medical Center
    Dallas, Texas

    Stuart C. Gordon, MD
    Professor of Medicine
    Wayne State University School of Medicine
    Director, Division of Hepatology
    Henry Ford Health
    Detroit, Michigan

    Pam Rivard, RN
    Person living with PBC

    Link to full program:
    https://bit.ly/4gDGDaB

  • In this episode, Jean-Michel Molina, MD, PhD, and Joseph J. Eron, Jr., MD, discuss results from key clinical trials on HIV prevention and treatment as well as sexually transmitted infection (STI) prevention presented at IDWeek and Glasgow 2024, including:

    PURPOSE 1 and 2 comparing lenacapavir injection vs oral TDF/FTCTRIO Health Cohort and OPERA examining long-acting cabotegravir as PrEPDOLCE comparing DTG/3TC as first-line therapy in treatment-naive patients with HIVPRIDOX evaluating the use of DoxyPEP on STI incidence in men who have sex with men on PrEP


    Presenters:

    Jean-Michel Molina, MD, PhD
    Professor of Infectious Diseases
    University of Paris Cité
    Head of the Department of Infectious Diseases
    Hospital Saint-Louis and lariboisière
    Paris, France

    Joseph J. Eron, Jr., MD
    Professor of Medicine, School of Medicine
    Herman and Louise Smith Distinguished Professor
    Chief, Division of Infectious Diseases
    Director, Clinical Core, UNC Center for AIDS Research
    Adjunct Professor of Epidemiology, Gillings School of Global Public Health
    University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina

    Link to full program:
    https://bit.ly/3BBaZvJ

  • In this episode, Christopher L. Bowlus, MD, discusses recent advances in the management of primary biliary cholangitis (PBC), including:

    Treatment goalsUse of PPAR agonists for the treatment of PBCClinical trial results for elafibranor (ELATIVE), seladelpar (RESPONSE), and bezafibrate (BEZURSO)

    Presenter:

    Christopher L. Bowlus, MD
    Lena Valente Professor and Chief
    Division of Gastroenterology and Hepatology
    University of California Davis School of Medicine
    Sacramento, California

    Link to full program:
    https://bit.ly/41tvSDu

    Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

  • In this episode, a transfemme nonbinary individual living with HIV shares her experience navigating the healthcare system, alongside her infectious disease physician, Michelle D. Collins-Ogle, MD, FAAP, FPIDS, AAHIVS. Hear them discuss key considerations when caring for gender-diverse individuals, including:

    Understanding how people are more than just a diagnosis Prioritizing individuals’ needs and providing whole-person care using shared decision-makingStrategies to make an environment more affirming and welcoming How to be an ally to transgender individualsListen to the individual in front of youHear what they’re telling youMake sure they are being affirmed and seen

    Link to the full program:
    https://bit.ly/3AAOGpv

    Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

  • In this rapid webinar, Meredith E. Clement, MD, and Linda-Gail Bekker, MBChB, DTMH, DCH, FCP(SA), PhD, provide an overview of important topics and studies presented at HIVR4P 2024, including:

    Expanding PrEP options based on results from PURPOSE 2, IMPOWER-22, IMPOWER-24, IPM 054, MTN-025/HOPE OLE, CATALYST, and the HPTN 084 substudyImplementing injectable PrEP based on results from PEPFAR, the USAID DISCOVER-Health LA CAB Demonstration Project in Zambia, and the LA CAB PrEP Rapid Start Model in Public Health ClinicsImproving PrEP uptake based on results from SPrEP and HPTN 091

    Presenters:

    Meredith E. Clement, MD
    Associate Professor
    Infectious Diseases
    Louisiana State University Health Sciences Center
    New Orleans, Louisiana

    Linda-Gail Bekker, MBChB, DTMH, DCH, FCP(SA), PhD
    Director and Professor, The Desmond Tutu HIV Centre, UCT
    CEO, The Desmond Tutu Health Foundation
    Cape Town, South Africa

    To access all of our new podcast episodes, subscribe to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. 

    Link to full program:
    https://bit.ly/3NJIDSA

  • Listen in as Rebekah Fenton, MD, MPH, and Sharon G. Humiston, MD, MPH, discuss strategies to achieve health equity in HPV vaccination, including:

    Trends among males vs femalesMessaging considerations for those from diverse populations (eg, LGTBQ+ and rural communities)How healthcare professionals can address barriers to care

    Then, hear answers from the experts to frequently asked questions regarding HPV vaccination recommendations, timing, and example case studies.

    Presenters:
    Rebekah Fenton, MD, MPH
    Adolescent Medicine Physician
    Alivio Medical Center
    Chicago, Illinois

    Sharon G. Humiston, MD, MPH
    Director for Research
    Associate Editor of IZ-Express
    Immunize.org
    Rochester, New York

    To access all of our new podcast episodes, subscribe to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. 

    Follow along with the slides:
    https://bit.ly/4flDxYb

    Link to full program:
    https://bit.ly/4f06tW4

  • In this rapid webinar, Meredith E. Clement, MD, and Linda-Gail Bekker, MBChB, DTMH, DCH, FCP(SA), PhD, provide an overview of important topics and studies presented at HIVR4P 2024, including:

    Expanding PrEP options based on results from PURPOSE 2, IMPOWER-22, IMPOWER-24, IPM 054, MTN-025/HOPE OLE, CATALYST, and the HPTN 084 substudyImplementing injectable PrEP based on results from PEPFAR, the USAID DISCOVER-Health LA CAB Demonstration Project in Zambia, and the LA CAB PrEP Rapid Start Model in Public Health ClinicsImproving PrEP uptake based on results from SPrEP and HPTN 091


    Presenters:

    Meredith E. Clement, MD
    Associate Professor
    Infectious Diseases
    Louisiana State University Health Sciences Center
    New Orleans, Louisiana

    Linda-Gail Bekker, MBChB, DTMH, DCH, FCP(SA), PhD
    Director and Professor, The Desmond Tutu HIV Centre, UCT
    CEO, The Desmond Tutu Health Foundation
    Cape Town, South Africa

    To access all of our new podcast episodes, subscribe to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. 

    Link to full program:
    https://bit.ly/3NJIDSA

  • Listen in as Rebekah Fenton, MD, MPH, and Sharon G. Humiston, MD, MPH, discuss strategies to improve your messaging techniques with the HPV vaccine, including:

    Persisting in vaccine recommendation after initial refusalEducating patients and their families togetherEnsuring staff are trained to correctly answer questionsKnowing when interested patients in your state can consent to vaccination without needing parental consent

    Presenters:
    Rebekah Fenton, MD, MPH
    Adolescent Medicine Physician
    Alivio Medical Center
    Chicago, Illinois

    Sharon G. Humiston, MD, MPH
    Director for Research
    Associate Editor of IZ-Express
    Immunize.org
    Rochester, New York

    To access all of our new podcast episodes, subscribe to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. 

    Follow along with the slides:
    https://bit.ly/4flDxYb

    Link to full program:
    https://bit.ly/4f06tW4

  • Listen in as Sharon G. Humiston, MD, MPH, discusses current trends in HPV, including:

    Incidence and prevalence trends in the USSex-related features of HPV-attributable cancersHow HPV vaccination uptake can prevent certain types of cancerCurrent guidelines and recommendations for HPV vaccination

    Presenter:
    Sharon G. Humiston, MD, MPH
    Director for Research
    Associate Editor of IZ-Express
    Immunize.org
    Rochester, New York

    To access all of our new podcast episodes, subscribe to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify. 

    Follow along with the slides:
    https://bit.ly/4flDxYb

    Link to full program:
    https://bit.ly/4f06tW4

  • In this episode, Kathleen Page, MD, and Glenn J. Treisman, MD, PhD, discuss the interplay between addiction and HIV. Learn as they share their approaches to reframing the conversation about addiction and overcoming barriers to effective addiction care for people living with HIV.

    Presenters:

    Kathleen Page, MD
    Professor
    Infectious Diseases
    Johns Hopkins School of Medicine
    Baltimore, Maryland

    Glenn J. Treisman, MD, PhD
    Eugene Meyer III Professor of Psychiatry and Medicine
    Johns Hopkins University School of Medicine
    Baltimore, Maryland

    Downloadable slides:
    https://bit.ly/3TR3OVV

    Program:
    https://bit.ly/3WB2VCO